This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

ANI Pharmaceuticals Inc (ANIP)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 169.04M 11.10M 34.79M 57.23M
Receivables 17.30M 12.51M 0.00 0.00
Inventories 7.52M 3.52M 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 203.48M 27.72M 35.17M 58.03M
Property, Plant & Equipment, Gross 9.02M 7.73M 557.95K 1.29M
Accumulated Depreciation & Depletion 3.79M 3.20M 391.56K 426.09K
Property, Plant & Equipment, Net 5.22M 4.54M 166.39K 861.36K
Intangibles 42.07M 10.41M 0.00 0.00
Other Non-Current Assets 3.31M 0.00 3.43M 3.49M
Total Non-Current Assets 60.23M 16.78M 3.60M 4.35M
Liabilities & Shareholder Equity
Total Assets 263.71M 44.50M 38.77M 62.38M
Accounts Payable 2.65M 1.43M 1.13M 3.15M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 5.70M 736.00K 0.00 0.00
Total Current Liabilities 13.23M 3.54M 10.59M 7.23M
Long Term Debt 110.69M 0.00 0.00 17.34M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 110.69M 0.00 0.00 17.34M
Total Liabilities 123.92M 3.54M 10.59M 24.56M
Preferred Stock Equity 0.00 0.00 391.00 391.00
Common Stock Equity 139.78M 40.96M 28.18M 37.81M
Common Par 1.00K 1.00K 273.13M 255.05M
Additional Paid In Capital 159.51M 89.50M 0.00 0.00
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -19.72M -48.47M -244.96M -217.24M
Treasury Stock 0.00 -68.00K 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 250.48M 40.96M 28.18M 55.15M
Total Equity 139.78M 40.96M 28.18M 37.82M
Total Liabilities & Stock Equity 263.71M 44.50M 38.77M 62.38M
Total Common Shares Outstanding 11.40M 9.63M 4.14M 3.44M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 9.23K 0.00 0.00
Basic Weighted Shares Outstanding 10.94M 5.07M 3.63M 2.73M
Diluted Weighted Shares Outstanding 11.05M 5.07M 3.63M 2.73M
Number of Employees 92 81 12 54
Number of Part-Time Employees 0 0 0 0
ANIP News

ANIP ANI Pharmaceuticals Inc

Analysts Ratings for ANIP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ANIP ANALYST REPORT

Brokerage Partners

ANIP Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs